@misc{indiciaec3da8232ede1,
  title = {Expanding the HDAC druggable landscape beyond enzymatic inhibition},
  author = {Olivet, J. and Choi, S. G. and Sierra, S. and O'Grady, T. M. and de la Fuente Revenga, M. and Laval, F. and Botchkarev, V. V. and Gorgulla, C. and Coote, P. W. and Blavier, J. and Geffken, E. A. and Lakhani, J. and Song, K. and Yeoh, Z. C. and Hu, B. and Varca, A. C. and Bruyr, J. and Ibrahim, S. and Jivanjee, T. and Bromley, J. D. and Nyquist, S. K. and Richardson, A. and Yue, H. and Wang, Y. and Calonghi, N. and Stephan, A. and Spirohn, K. and Vertommen, D. and Baietti, M. F. and Lemmens, I. and Seo, H.-S. and Dozmorov, M. G. and Willems, L. and Tavernier, J. and Das, K. and Leucci, E. and Hochkoeppler, A. and Sun, Z.-Y. J. and Calderwood, M. A. and Hao, T. and Shalek, A. K. and Hill, D. E. and Boeszoermenyi, A. and A},
  year = {2022},
  doi = {10.1101/2022.12.07.519454},
  url = {https://www.biorxiv.org/content/10.1101/2022.12.07.519454v1},
  note = {Source identifier: 10.1101/2022.12.07.519454}
}